Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-10
2008-06-10
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S143000, C514S364000
Reexamination Certificate
active
07384963
ABSTRACT:
Compounds of formula (I), wherein R1is a phenyl group which may be optionally substituted; R2is selected from hydrogen, C1-6alkyl and (CH2)p—C3-7cycloalkyl; R3is the group: (Formula II), R4is selected from hydrogen and C1-4alkyl; U is selected from methyl and halogen; X and Y are each selected independently from hydrogen, methyl and halogen; m is selected from 0, 1, 2, 3 and 4, and may be optionally substituted with up to two groups selected independently from C1-6alkyl; n is selected from 0, 1 and 2; p is selected from 0, 1 and 2; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors
REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 4968804 (1990-11-01), Stanek et al.
patent: 5064832 (1991-11-01), Stanek et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5340810 (1994-08-01), Clitherow et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5877190 (1999-03-01), Dhainaut et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 6080767 (2000-06-01), Klein et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6323227 (2001-11-01), Klein et al.
patent: 6376546 (2002-04-01), Shoda et al.
patent: 6392047 (2002-05-01), Geissler et al.
patent: 6399627 (2002-06-01), Song et al.
patent: 6420561 (2002-07-01), Haruta et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6448257 (2002-09-01), Mavunkel et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509361 (2003-01-01), Weier et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6545054 (2003-04-01), Song et al.
patent: 6576632 (2003-06-01), Goldstein et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6605625 (2003-08-01), Peukert et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6696464 (2004-02-01), McClure et al.
patent: 6699994 (2004-03-01), Babu et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6794377 (2004-09-01), Peukert et al.
patent: 6821965 (2004-11-01), Brown et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6867209 (2005-03-01), Mavunkel et al.
patent: 6924392 (2005-08-01), Peukert et al.
patent: 6936719 (2005-08-01), Babu et al.
patent: 6956037 (2005-10-01), Brown et al.
patent: 7125898 (2006-10-01), Aston et al.
patent: 7151118 (2006-12-01), Angell et al.
patent: 7166623 (2007-01-01), Angell et al.
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2003/0055088 (2003-03-01), Shao et al.
patent: 2003/0139605 (2003-07-01), Riedl et al.
patent: 2003/0225089 (2003-12-01), Jung et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 2004/0116479 (2004-06-01), Haviv et al.
patent: 2004/0138287 (2004-07-01), Barth et al.
patent: 2004/0162281 (2004-08-01), Babu et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0254200 (2004-12-01), Davis et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020540 (2005-01-01), Angell et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 2006/0089393 (2006-04-01), Angell et al.
patent: 2006/0122221 (2006-06-01), Angell et al.
patent: 2006/0241179 (2006-10-01), Aston
patent: 2006/0264479 (2006-11-01), Aston et al.
patent: 2006/0276516 (2006-12-01), Aston et al.
patent: 0 533 266 (1992-09-01), None
patent: 0 533 268 (1993-03-01), None
patent: 0 346 841 (2003-06-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 276 162 (1993-03-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 276 161 (1994-09-01), None
patent: 2 295 387 (1996-05-01), None
patent: 11218884 (1999-08-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: 96/31508 (1996-10-01), None
patent: WO 96/31509 (1996-10-01), None
patent: WO 97/03034 (1997-01-01), None
patent: WO 98/57934 (1998-12-01), None
patent: 99/32463 (1999-07-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: WO 01/87875 (2001-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 2004/010995 (2004-02-01), None
patent: WO 2004/089874 (2004-10-01), None
patent: WO 2004/089875 (2004-10-01), None
patent: WO 2004/089876 (2004-10-01), None
patent: WO 2005/014550 (2005-02-01), None
patent: WO 2006/110173 (2006-10-01), None
Co-pending U.S. Appl. No. 10/492,711 to Angell, R. et al.
Trojanowski, John Q. “Alzheimer's Disease, Parkinson's Disease and Related Brain Disorders: Brief Overview for Patients and Caregivers.” Internet article, Univ. Penn. Health System, Oct. 1999.
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Boehm, et al,Journal of Medicinal Chemistry, vol. 39(20) pp. 3929-3937 (1996).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001).
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Research, vol. 1265 (2-3) pp. 224-227 (1995.
Hanson,Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
Courtney, S. et al.,Bioorganic&Medicinal Chemistry Letters, vol. 14 pp. 3269-3273(2004).
Foster, et al.,Drug News Perspect., vol. 13(8) pp. 488-497. (2000).
Henry, et al.,Biorganic&Medicinal Chemistry Letters, vol. 8 pp. 3335-3340 (1998).
Marin, et al.,Blood, vol. 98(3) pp. 667-673 (2001).
Underwood, et al.,Journal of Pharmacology and Experimental Therapeutics, vol. 293 (1) pp. 281-288 (2000).
Wadsworth, et al.,Journal of Pharmacology and Experimental Therapeutics, vol. 291(2) pp. 680-687 (1999).
Herlaar, et al., Molecular Medicine Today, vol. 5 pp. 439-447 (1999).
U.S. Appl. No. 10/492,714, filed Apr. 15, 2004, Angell et al.
U.S. Appl. No. 10/568,121, filed Feb. 9, 2006, Walker, A.
U.S. Appl. No. 10/551,503, filed Sep. 30, 2005, Aston, N.
U.S. Appl. No. 10/551,502, filed Sep. 30,
Angell Richard Martyn
Bamborough Paul
Cockerill George Stuart
Walker Ann Louise
Coppins Janet L.
Dinner Dara L.
Furman Theodore R.
Glaxo Group Limited
Kinzig Charles M.
LandOfFree
2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2802907